01-11-2021 | Vulgar Psoriasis | Letter to the Editor
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”
Published in: American Journal of Clinical Dermatology | Issue 6/2021
Login to get access